Biotech Cellectar Receives Orphan Drug Designation from the European Commission for CLR 131 in Waldenstrom’s Macroglobulinemia January 27, 2021
Biotech Immutep Announces Advancement Of Phase II Trial For Eftilagimod Alpha In Covid-19 Patients To Randomised Portion Of The Study January 27, 2021
Biotech Heat Biologics Announces Publication of Additional Preclinical COVID-19 Vaccine Results January 27, 2021
Biotech Broad-Spectrum Direct Antiviral Nanomedicine Should Remain Effective Against COVID-19 Virus Variants, Says NanoViricides, Inc.’s President, Dr. Anil Diwan January 27, 2021
Biotech CELSION CORPORATION ANNOUNCES CLOSING OF $35 MILLION REGISTERED DIRECT OFFERING OF COMMON STOCK PRICED AT-THE-MARKET UNDER NASDAQ RULES January 26, 2021
Biotech Aeterna Zentaris Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Rule January 26, 2021
Biotech FBIO Final Deadline: Bronstein, Gewirtz & Grossman, LLC Reminds Fortress Biotech, Inc. Investors With Losses Exceeding $600,000 of Class Action and Lead Plaintiff Deadline: January 26, 2021 January 26, 2021
Search
Biotech
January 27, 2021
January 27, 2021
January 27, 2021
January 27, 2021
January 27, 2021
January 27, 2021
January 26, 2021
January 26, 2021
January 26, 2021
January 26, 2021
